Variant report
Variant | nsv982156 |
---|---|
Chromosome Location | chr9:6164201-6171397 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:6163094..6165877-chr9:6167250..6170974,4 | K562 | blood: | |
2 | chr9:6163920..6166108-chr9:6170937..6173147,2 | MCF-7 | breast: | |
3 | chr13:43706108..43706705-chr9:6170816..6171542,2 | MCF-7 | breast: | |
4 | chr9:6149075..6150608-chr9:6166608..6168151,2 | MCF-7 | breast: | |
5 | chr9:6163920..6166108-chr9:6170937..6173147,2 | MCF-7 | breast: | |
6 | chr9:6163094..6165877-chr9:6167250..6170974,4 | K562 | blood: | |
7 | chr9:6163367..6165821-chr9:6169712..6171511,2 | K562 | blood: | |
8 | chr9:6163367..6165821-chr9:6169712..6171511,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571364976 | chr9:6164205-6164206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148526885 | chr9:6164271-6164272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370058980 | chr9:6164283-6164284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557005898 | chr9:6164332-6164333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541942255 | chr9:6164333-6164334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188266521 | chr9:6164353-6164354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369509992 | chr9:6164403-6164404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370490813 | chr9:6164409-6164410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542930514 | chr9:6164477-6164478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543995486 | chr9:6164491-6164492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554547184 | chr9:6164516-6164517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573026321 | chr9:6164535-6164536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs16924068 | chr9:6164596-6164597 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs113034140 | chr9:6164597-6164598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190615407 | chr9:6164598-6164599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182900212 | chr9:6164600-6164601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187626127 | chr9:6164649-6164650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142861076 | chr9:6164650-6164651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547036660 | chr9:6164653-6164654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374131768 | chr9:6164654-6164655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192406655 | chr9:6164664-6164665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548889598 | chr9:6164671-6164672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567045486 | chr9:6164723-6164724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527935068 | chr9:6164753-6164754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116668957 | chr9:6164769-6164770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7863536 | chr9:6164771-6164772 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs538755207 | chr9:6164773-6164774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557065145 | chr9:6164794-6164795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545750983 | chr9:6164805-6164806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568900012 | chr9:6164806-6164807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376165744 | chr9:6164847-6164848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535854149 | chr9:6164889-6164890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554887727 | chr9:6164923-6164924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150650798 | chr9:6164952-6164953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184819809 | chr9:6164976-6164977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs16924070 | chr9:6164977-6164978 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs144873854 | chr9:6164980-6164981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544319775 | chr9:6164992-6164993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187334205 | chr9:6165008-6165009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530150786 | chr9:6165016-6165017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573906854 | chr9:6165031-6165032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147943896 | chr9:6165043-6165044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370872900 | chr9:6165079-6165080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560453135 | chr9:6165082-6165083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527988992 | chr9:6165092-6165093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200345292 | chr9:6165114-6165115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552870580 | chr9:6165149-6165150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs564691327 | chr9:6165151-6165152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559447190 | chr9:6165177-6165178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141865429 | chr9:6165181-6165182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:6160200-6173600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr9:6165600-6165800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr9:6165600-6166200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr9:6166200-6166400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr9:6166400-6166800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr9:6166600-6167000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr9:6166800-6167000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr9:6166800-6171000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
9 | chr9:6168600-6168800 | Bivalent Enhancer | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr9:6170600-6172000 | Enhancers | Fetal Kidney | kidney |
11 | chr9:6170800-6172800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr9:6170800-6172800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr9:6171000-6171600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr9:6171000-6172600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr9:6171000-6172800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr9:6171000-6172800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr9:6171000-6172800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr9:6171000-6172800 | Enhancers | NHDF-Ad | bronchial |